Microbiology and Clinical Outcome of Bloodstream Infections in Patients After Hematopoietic Stem Cell Transplantation

References

• Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant. 2007;40(1):63–70. doi:10.1038/sj.bmt.1705690
   PubMed Web of Science ®Google Scholar
• Esquirol A, Pascual MJ, Kwon M, et al. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant. 2021;56(10):2432–2444. doi:10.1038/s41409-021-01328-4
   PubMed Web of Science ®Google Scholar
• Willis DN, McGlynn MC, Reich PJ, Hayashi RJ. Mortality in pediatric oncology and stem cell transplant patients with bloodstream infections. Front Oncol. 2022;12:1063253. doi:10.3389/fonc.2022.1063253
   PubMed Web of Science ®Google Scholar
• Ohbayashi Y, Imataki O, Uemura M, et al. Oral microorganisms and bloodstream infection in allogeneic hematopoietic stem cell transplantation. Clin Oral Investig. 2021;25(7):4359–4367. doi:10.1007/s00784-020-03749-9
   PubMed Web of Science ®Google Scholar
• Akhmedov M, Klyasova G, Kuzmina L, Parovichnikova E. Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation. Expert Rev Anti Infect Ther. 2023;21(1):87–90. doi:10.1080/14787210.2023.2151440
   PubMed Web of Science ®Google Scholar
• Zeng Q, Xiang B, Liu Z. Profile and antibiotic pattern of blood stream infections of patients receiving hematopoietic stem cell transplants in Southwest China. Infect Drug Resist. 2022;15:2045–2054. doi:10.2147/IDR.S358926
   PubMed Web of Science ®Google Scholar
• Heston SM, Young RR, Hong H, et al. Microbiology of bloodstream infections in children after hematopoietic stem cell transplantation: a single-center experience over two decades (1997–2017). Open Forum Infect Dis. 2020;7(11):ofaa465. doi:10.1093/ofid/ofaa465
   PubMed Web of Science ®Google Scholar
• Ustun C, Young JH, Papanicolaou GA, et al. Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2019;54(8):1254–1265. doi:10.1038/s41409-018-0401-4
   PubMed Web of Science ®Google Scholar
• Yan CH, Wang Y, Mo XD, et al. Incidence, risk factors, microbiology and outcomes of pre-engraftment bloodstream infection after haploidentical hematopoietic stem cell transplantation and comparison with HLA-identical sibling transplantation. Clin Infect Dis. 2018;67(suppl_2):S162–S173. doi:10.1093/cid/ciy658
   PubMedGoogle Scholar
• Gill J, Busca A, Cinatti N, et al. Bacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation: etiology, risk factors and outcome in a single-center study. Microorganisms. 2023;11(3):742. doi:10.3390/microorganisms11030742
   PubMed Web of Science ®Google Scholar
• Ferreira AM, Moreira F, Guimaraes T, et al. Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization. J Hosp Infect. 2018;100(1):83–91. doi:10.1016/j.jhin.2018.03.004
   PubMed Web of Science ®Google Scholar
• Papanicolaou GA, Ustun C, Young JH, et al. Bloodstream infection due to vancomycin-resistant enterococcus is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: a multicenter, retrospective cohort study. Clin Infect Dis. 2019;69(10):1771–1779. doi:10.1093/cid/ciz031
   PubMed Web of Science ®Google Scholar
• Bes T, Nagano D, Martins R, et al. Bloodstream infections caused by Klebsiella pneumoniae and Serratia marcescens isolates co-harboring NDM-1 and KPC-2. Ann Clin Microbiol Antimicrob. 2021;20(1):57. doi:10.1186/s12941-021-00464-5
   PubMed Web of Science ®Google Scholar
• Chen J, Ma H, Huang X, et al. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study. Antimicrob Resist Infect Control. 2022;11(1):161. doi:10.1186/s13756-022-01204-w
   PubMed Web of Science ®Google Scholar
• Mori Y, Yoshimoto G, Nishida R, et al. Gastrointestinal graft-versus-host disease is a risk factor for postengraftment bloodstream infection in allogeneic hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2018;24(11):2302–2309. doi:10.1016/j.bbmt.2018.06.002
   PubMed Web of Science ®Google Scholar
• Mikulska M, Del Bono V, Bruzzi P, et al. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection. 2012;40(3):271–278. doi:10.1007/s15010-011-0229-y
   PubMed Web of Science ®Google Scholar
• Zhu Q, Xu J, Chen X, Ren Y, Zhao L. Risk factors and molecular epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae. Diagn Microbiol Infect Dis. 2023;106(3):115955. doi:10.1016/j.diagmicrobio.2023.115955
   PubMed Web of Science ®Google Scholar
• Chen W, Zhao Y, Luo Y, et al. Clinical characteristics, microbiology, and risk factors for mortality of pre-engraftment and post-engraftment bloodstream infection in hematopoietic stem cell transplantation recipients. Infect Drug Resist. 2022;15:6893–6905. doi:10.2147/IDR.S392804
   PubMed Web of Science ®Google Scholar
• Han QZ, Chen Y, Yang H, et al. 血流感染在1265例造血干细胞移植患者中的发生情况及病原菌分析 [Incidence of blood stream infections of 1265 patients with hematopoietic stem cell transplantation and analysis of pathogenic bacteria]. Zhonghua Xue Ye Xue Za Zhi. 2017;38(11):930–933. Chinese. doi:10.3760/cma.j.issn.0253-2727.2017.11.005
   PubMedGoogle Scholar
• Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant. 2011;46(2):300–307. doi:10.1038/bmt.2010.112
   PubMed Web of Science ®Google Scholar
• Hong J, Moon SM, Ahn HK, et al. Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(6):994–999. doi:10.1016/j.bbmt.2013.03.019
   PubMed Web of Science ®Google Scholar
• Girmenia C, Bertaina A, Piciocchi A, et al. Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian Prospective Multicenter Survey. Clin Infect Dis. 2017;65(11):1884–1896. doi:10.1093/cid/cix690
   PubMed Web of Science ®Google Scholar
• Young JH, Logan BR, Wu J, et al. Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors. Biol Blood Marrow Transplant. 2016;22(2):359–370. doi:10.1016/j.bbmt.2015.09.013
   PubMed Web of Science ®Google Scholar
• Takagi S, Ogura S, Araoka H, et al. The impact of graft cell source on bloodstream infection in the first 100 days after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2021;56(7):1625–1634. doi:10.1038/s41409-021-01229-6
   PubMed Web of Science ®Google Scholar
• Forcina A, Lorentino F, Marasco V, et al. Clinical impact of pretransplant multidrug-resistant gram-negative colonization in autologous and allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018;24(7):1476–1482. doi:10.1016/j.bbmt.2018.02.021
   PubMed Web of Science ®Google Scholar
• Akinboyo IC, Young RR, Spees LP, et al. Microbiology and risk factors for hospital-associated bloodstream infections among pediatric hematopoietic stem cell transplant recipients. Open Forum Infect Dis. 2020;7(4):ofaa093. doi:10.1093/ofid/ofaa093
   PubMed Web of Science ®Google Scholar
• Puerta-Alcalde P, Cardozo C, Marco F, et al. Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes. Bone Marrow Transplant. 2020;55(3):603–612. doi:10.1038/s41409-019-0701-3
   PubMed Web of Science ®Google Scholar
• Cao W, Guan L, Li X, et al. Clinical analysis of bloodstream infections during agranulocytosis after allogeneic hematopoietic stem cell transplantation. Infect Drug Resist. 2021;14:185–192. doi:10.2147/IDR.S280869
   PubMed Web of Science ®Google Scholar
• Castagnola E, Bagnasco F, Mesini A, et al. Antibiotic resistant bloodstream infections in pediatric patients receiving chemotherapy or hematopoietic stem cell transplant: factors associated with development of resistance, intensive care admission and mortality. Antibiotics. 2021;10(3):266. doi:10.3390/antibiotics10030266
   Google Scholar
• Trecarichi EM, Pagano L, Martino B, et al. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. Am J Hematol. 2016;91(11):1076–1081. doi:10.1002/ajh.24489
   PubMed Web of Science ®Google Scholar
• Cao W, Zhang J, Bian Z, et al. Active screening of intestinal colonization of carbapenem-resistant Enterobacteriaceae for subsequent bloodstream infection in allogeneic hematopoietic stem cell transplantation. Infect Drug Resist. 2022;15:5993–6006. doi:10.2147/IDR.S387615
   PubMed Web of Science ®Google Scholar
• Royo-Cebrecos C, Laporte-Amargos J, Pena M, et al. Pseudomonas aeruginosa bloodstream infections in patients with cancer: differences between patients with hematological malignancies and solid tumors. Pathogens. 2022;11(10):1132. doi:10.3390/pathogens11101132
   PubMed Web of Science ®Google Scholar
• Vydra J, Shanley RM, George I, et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012;55(6):764–770. doi:10.1093/cid/cis550
   PubMed Web of Science ®Google Scholar
• Öksüz L, Hindilerden I Y, Erciyestepe M, et al. The association of CMV infection with bacterial and fungal infections in hematopoietic stem cell transplant recipients: a retrospective single-center study. New Microbiol. 2022;45(1):40–50.
   PubMed Web of Science ®Google Scholar
• Chen X-C, Xu J, Wu D-P. Clinical characteristics and implications of mixed candida/bacterial bloodstream infections in patients with hematological diseases. Eur J Clin Microbiol Infect Dis. 2020;39(8):1445–1452. doi:10.1007/s10096-020-03863-2
   PubMed Web of Science ®Google Scholar
• Criscuolo M, Marchesi F, Candoni A, et al. Fungaemia in haematological malignancies: SEIFEM-2015 survey. Eur J Clin Invest. 2019;49(5):e13083. doi:10.1111/eci.13083
   PubMed Web of Science ®Google Scholar
• Dandoy CE, Kim S, Chen M, et al. Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant. JAMA Netw Open. 2020;3(1):e1918668. doi:10.1001/jamanetworkopen.2019.18668
   PubMed Web of Science ®Google Scholar
• Dandoy CE, Haslam D, Lane A, et al. Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation. Biol Blood Marrow Transplant. 2016;22(9):1671–1677. doi:10.1016/j.bbmt.2016.06.002
   PubMed Web of Science ®Google Scholar